These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 5696290)

  • 1. Heparin-MnCl2 removal of nonspecific serum inhibitor for measles virus hemagglutinin.
    Feldman HA
    J Immunol; 1968 Jun; 100(6):1353-4. PubMed ID: 5696290
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of adsorbents on IgM and IgG measles antibodies.
    Polna I; Aleksandrowicz J
    Acta Virol; 1975 Nov; 19(6):449-56. PubMed ID: 1989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Removal of nonspecific inhibitors in the Rubella virus hemagglutination inhibition test employing acetone as compared to kaolin and heparin-MnCl2 pretreatment (author's transl)].
    Marklein G; Göbel U; Schäfer E
    Zentralbl Bakteriol Orig A; 1974; 229(3):290-8. PubMed ID: 4155878
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of kaolin on immunoglobulins: an improved technique to remove the nonspecific serum inhibitor of reovirus hemagglutination.
    Mann JJ; Rossen RD; Lehrich JR; Kasel JA
    J Immunol; 1967 Jun; 98(6):1136-42. PubMed ID: 4165228
    [No Abstract]   [Full Text] [Related]  

  • 5. [The hemagglutination inhibition reaction in the diagnosis of rubella. Apropos of the critical and comparative study of 252 serums treated by heparin-MnCl2 and allowed to react with trypsin treated human O erytrocytes].
    Dalle M; Bajolle F; Croix JC
    Ann Biol Clin (Paris); 1974; 32(5):433-8. PubMed ID: 4457025
    [No Abstract]   [Full Text] [Related]  

  • 6. Contribution to the serologic diagnosis of rubella. Application of a modified hemagglutination and hemagglutination inhibition method.
    Măgureanu E; Grobnicu M; Botez D
    Rev Roum Inframicrobiol; 1971; 8(3):163-7. PubMed ID: 5152645
    [No Abstract]   [Full Text] [Related]  

  • 7. Removal by heparin-MnCl2 of nonspecific rubella hemagglutinin serum inhibitor.
    Feldman HA
    Proc Soc Exp Biol Med; 1968 Feb; 127(2):570-3. PubMed ID: 5689482
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on the removal of nonspecific inhibitors and heteroagglutinins in the parainfluenza-hemagglutination inhibition test (author's transl)].
    Herrmann R; Döhner L
    Pathol Microbiol (Basel); 1974; 40(6):305-15. PubMed ID: 4368268
    [No Abstract]   [Full Text] [Related]  

  • 9. A simple method for removal of rubella hemagglutination inhibitors from serum adaptable to finger-tip blood.
    Plotkin SA; Bechtel DJ; Sedwick WD
    Am J Epidemiol; 1968 Nov; 88(3):301-4. PubMed ID: 4972370
    [No Abstract]   [Full Text] [Related]  

  • 10. Experience with a modified rubella hemagglutination inhibition antibody test.
    Cooper LZ; Matters B; Rosenblum JK; Krugman S
    JAMA; 1969 Jan; 207(1):89-93. PubMed ID: 5818144
    [No Abstract]   [Full Text] [Related]  

  • 11. [Research of hemoagglutinoinhibiting antibodies against measles virus in a sample of population from Accra (Ghana)].
    Balestrieri A; D'Arrigo C; Russo V
    Arch Ital Sci Med Trop Parassitol; 1968; 49(1):49-54. PubMed ID: 5740693
    [No Abstract]   [Full Text] [Related]  

  • 12. Loss of rubella antibody from immune globulin treated with kaolin.
    Cabasso VJ; Louie RE; Hok KA; Robinson CT; Davis PC; Miner RC
    Appl Microbiol; 1969 Sep; 18(3):410-5. PubMed ID: 4190525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Raising of the level of antibodies inhibiting the measles virus hemagglutination in the course of acute aseptic meningitis].
    Bricout F; Bouvier A; Regnard J
    Ann Inst Pasteur (Paris); 1970 Feb; 118(2):235-8. PubMed ID: 5416574
    [No Abstract]   [Full Text] [Related]  

  • 14. The nonspecific inhibitors of rubella-virus hemagglutination.
    Dold HJ; Northrop RL
    Proc Soc Exp Biol Med; 1968 Jun; 128(2):577-81. PubMed ID: 5663277
    [No Abstract]   [Full Text] [Related]  

  • 15. Relative contributions of measles virus hemagglutinin- and fusion protein-specific serum antibodies to virus neutralization.
    de Swart RL; Yüksel S; Osterhaus AD
    J Virol; 2005 Sep; 79(17):11547-51. PubMed ID: 16103210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles virus haemagglutination-inhibition antibodies among pregnant and non-pregnant women in the vaccine era in Harare, Zimbabwe.
    Obi CL; Tswana SA; Moyo SR; Berejena C
    Cent Afr J Med; 1996 May; 42(5):135-8. PubMed ID: 8771931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results of a trial of an erythrocyte measles diagnostic agent in public health institutions].
    Polzik TP; Kashkina GB; Andrianova DP; Bol'shakova SL; Petrova MA
    Tr Inst Im Pastera; 1981; 56():112-4. PubMed ID: 6764964
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies on the hemagglutinin of measles virus. Action of various reducing agents].
    Dianzani F
    Boll Soc Ital Biol Sper; 1964 Apr; 40(7):302-5. PubMed ID: 4960692
    [No Abstract]   [Full Text] [Related]  

  • 19. [Status of immunization against measles in the pediatric population of the province of Ferrara].
    Bezzi TM; Soriani S; Trombini R; Scorrano M
    Minerva Pediatr; 1980 Apr; 32(8):581. PubMed ID: 7393191
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparison between the plaque reduction neutralization test and the hemagglutination inhibition test in determination of human anti-measles antibodies].
    Kong J; Guo SH; Ze WY
    Zhonghua Liu Xing Bing Xue Za Zhi; 1996 Apr; 17(2):105-7. PubMed ID: 8758407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.